NLM Digital Collections

Search

Start Over Subjects Multiple Sclerosis, Chronic Progressive -- drug therapy ✖Remove constraint Subjects: Multiple Sclerosis, Chronic Progressive -- drug therapy

1. Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report

Publication:
Boston, MA : Institute for Clinical and Economic Review, March 6, 2017
Subject(s):
Comparative Effectiveness Research
Multiple Sclerosis, Chronic Progressive -- drug therapy
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- economics
Antirheumatic Agents -- therapeutic use
Benchmarking
Cost-Benefit Analysis
Immunosuppressive Agents -- adverse effects
Immunosuppressive Agents -- economics
Immunosuppressive Agents -- therapeutic use
Insurance Coverage
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States

2. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Sharaf, Ravi, author
Synnott, Patricia, author
Samur, Sumeyye, author
Chapman, Rick M., author
Adair, Ellie, author
Rind, David, author
Pearson, Steve, author
O'Grady, Madeline, author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Multiple Sclerosis, Chronic Progressive -- drug therapy
Sphingosine 1 Phosphate Receptor Modulators
United States